Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study

  1. Adams, S.
  2. Schmid, P.
  3. Rugo, H.S.
  4. Winer, E.P.
  5. Loirat, D.
  6. Awada, A.
  7. Cescon, D.W.
  8. Iwata, H.
  9. Campone, M.
  10. Nanda, R.
  11. Hui, R.
  12. Curigliano, G.
  13. Toppmeyer, D.
  14. O'Shaughnessy, J.
  15. Loi, S.
  16. Paluch-Shimon, S.
  17. Tan, A.R.
  18. Card, D.
  19. Zhao, J.
  20. Karantza, V.
  21. Cortés, J.
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2019

Volumen: 30

Número: 3

Pages: 397-404

Type: Article

DOI: 10.1093/ANNONC/MDY517 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus